Amneal Pharmaceuticals, Inc.·4

May 7, 5:25 PM ET

Nark Ted C 4

4 · Amneal Pharmaceuticals, Inc. · Filed May 7, 2020

Insider Transaction Report

Form 4
Period: 2020-05-05
Nark Ted C
Director
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2020-05-07+6,45962,566 total
  • Award

    Restricted Stock Units

    2020-05-05+46,21846,218 total
    Class A Common Stock (46,218 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2020-05-076,4590 total
    Class A Common Stock (6,459 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
  • [F3]On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020.

Documents

2 files